NY-MSCI
9.9.2019 14:02:19 CEST | Business Wire | Press release
MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today that Salli Schwartz has been appointed Head of Investor Relations and Treasurer, effective September 16, 2019.
“We are thrilled that Salli is joining MSCI. Her 20 years in financial services, particularly in establishing and executing capital strategy, developing robust investor communication programs and managing relationships with shareholders, ratings agencies and sell side analysts, will ensure that we continue to maximize shareholder value,” said Linda S. Huber, Chief Financial Officer of MSCI.
“MSCI is continuing to evolve and grow rapidly, and I am excited to work with Linda and the Executive Committee to enhance its capital management strategy and to tell the company’s story to the investor community,” said Ms. Schwartz.
Ms. Schwartz previously served as the Global Head of Strategic Capital Management and Treasurer of Moody’s Corporation. She formed Moody’s Strategic Capital Management Group by combining the Investor Relations and Treasury teams, comprised of 20 global professionals. She also held other key senior positions during her 12-year tenure at Moody’s Corporation, including Global Head of Investor Relations and Communications as well as various Corporate Development roles. Ms. Schwartz began her career in Legg Mason’s investment banking group and was part of the financial management rotational program at Citigroup.
Ms. Schwartz holds an M.B.A. from the Johnson Graduate School of Management at Cornell University and a B.A. in History and Sociology of Science from the University of Pennsylvania.
About MSCI Inc.
MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 45 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process. To learn more, please visit www.msci.com . MSCI#IR
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond MSCI’s control and that could materially affect actual results, levels of activity, performance or achievements.
Other factors that could materially affect actual results, levels of activity, performance or achievements can be found in MSCI’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (“SEC”) on February 22, 2019 and in quarterly reports on Form 10-Q and current reports on Form 8-K filed or furnished with the SEC. If any of these risks or uncertainties materialize, or if MSCI’s underlying assumptions prove to be incorrect, actual results may vary significantly from what MSCI projected. Any forward-looking statement in this press release reflects MSCI’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MSCI’s operations, results of operations, growth strategy and liquidity. MSCI assumes no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005528/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Comrade Trustee Services goes live with Smartstream’s Air, the AI reconciliation and data automation solution11.6.2026 09:55:00 CEST | Press release
Key Facts Comrade Trustee Services is live on Smartstream’s Air for automated reconciliations with fully integrated workflows. The implementation replaces highly manual, spreadsheet-driven processes and complex file handling with a single-click, straight-through AI-driven workflow. This will improve accuracy, control and operational efficiency. Processing time has been reduced from up to eight hours to under five minutes, with additional scalability for complex file types, formats and reconciliation logic. Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces that Comrade Trustee Services Limited (CTSL), trustee for the Defence Force Retirement Benefit Fund in Papua New Guinea, has gone live with Smartstream’s Air, the AI reconciliation and data automation solution – cutting processing times from eight hours to under five minutes. The go-live delivers a fully automated, straight-through reconciliation workflow, enabl
Wolters Kluwer enhances its Libra legal AI workspace in Italy by adding content specializations for One and integrating with Kleos11.6.2026 09:00:00 CEST | Press release
Libra by Wolters Kluwer integrates AI with authoritative, expert-generated content and operational workflows, supporting legal professionals across the entire workflow Wolters Kluwer Legal & Regulatory announced today new content and feature integrations in its legal AI workspace Libra by Wolters Kluwer for the Italian market. Customers will have access to additional expert-generated content in compliance, criminal law and tax law, and profit from the integration with Kleos, the cloud-based practice management solution for law firms. Designed to support the daily work of legal professionals, Libra by Wolters Kluwer combines advanced AI functionalities with trusted sources and authoritative, author-generated legal content. Within a single environment, it enables research, analysis and drafting activities based on reliable sources, while maintaining full control over results and quality. By integrating additional expert content from One, Wolters Kluwer’s leading legal research platform,
Pleo Announces New Agentic Capabilities, Changing the Face of Financial Management and Decision-Making11.6.2026 09:00:00 CEST | Press release
Pleo’s new agentic capabilities to let finance teams focus on strategic command, not admin These new agentic capabilities offer a clear path forward for finance leaders: especially when 63% say AI skills, training and confidence are severely lagging. Pleo, Europe's first and most trusted strategic finance platform, today announces a suite of AI agents that handle routine spend management autonomously, so finance leaders can focus on decisions rather than administrative tasks. Finance teams are under growing pressure: 45% of European companies say their current processes slow them down, and leaders describe approval workflows as so cumbersome they struggle to operate at the required speed. Meanwhile, 73% believe the future of finance teams and professionals depends on the comprehensive understanding and use of AI, yet 63% say AI skills, training and confidence are severely lagging. Pleo's agentic AI addresses this gap. Starting with beta testing in July, Pleo is moving toward a model wh
BearingPoint Danmark leverer 85% omsætningsvækst i 2025 og offentliggør års- og bæredygtighedsrapport11.6.2026 09:00:00 CEST | Pressemeddelelse
Stærk kundeefterspørgsel, et banebrydende AI projekt med Danske Bank og en betydelig medarbejdervækst skaber fremdrift på det danske marked og omsætter Strategy 2030 til konkrete resultater i Danmark. BearingPoint Danmark opnåede en omsætningsvækst på 85% i 2025, drevet af stærk efterspørgsel efter AI og rådgivning til den finansielle sektor, i forbindelse med offentliggørelsen af virksomhedens Årsrapport 2025, ”Future in focus” samt Bæredygtighedsrapport 2025, som markerer overgangen fra strategi til konkret eksekvering. Rapporterne viser, hvordan virksomheden skalerer anvendelsen af AI på tværs af organisationen, styrker sin globale leverancemodel og integrerer bæredygtighed i både strategi og kundeleverancer. Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20260611802927/da/ BearingPoint Danmark opnåede en omsætningsvækst på 85% i 2025, drevet af stærk efterspørgsel efter AI og rådgivning til den finansielle sektor, i forb
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions11.6.2026 08:01:00 CEST | Press release
- Data from pivotal studies of CASGEVY in children ages 5–11 with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrate transformative potential in younger patients, consistent with the durable benefits established in patients 12 years and older -- Data simultaneously published in the New England Journal of Medicine -- Regulatory review underway in the United States to expand the use of CASGEVY, and Vertex has recently completed submissions in the Kingdom of Saudi Arabia and United Kingdom - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, from pivotal studies in children ages 5–11, show that the efficacy and safety outcomes in this age group are consistent with the transformative profile established in adult and adolescent p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
